Wednesday, February 10, 2010, 3:17am EST - Canadian Markets open in 6 hours and 13 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

3SBio Inc. (SSRX)

 On Feb 9: 10.18 USD   0.00 (0.00%)  
MORE ON SSRX
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
3SBio Inc. (NasdaqNM:SSRX) Delayed quote dataEdit
Last Trade: 10.18 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 10.18
Open: N/A
Bid: N/A
Ask: N/A
1y Target Est: 14.75
Day's Range: N/A - N/A
52wk Range: 4.18 - 14.45
Volume: 0
Avg Vol (3m): 98,919
Market Cap: 219.06M
P/E (ttm): N/A
EPS (ttm): N/A
Div & Yield: N/A (N/A%)
3SBio Inc. (SSRX)
1d  5d  3m  6m  1y  2y  5y 
Free Annual Reports
 Add SSRX to Portfolio   Download Data

HEADLINES
• 3SBio Gains China Rights to Another Dialysis Drug
at Seeking Alpha (Tue 2:43am)
• 3SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(R) for Hyperphosphatemia
PRNewswire (Mon, Feb 8)
• 3SBio Inc. to Report 2009 Fourth Quarter and Full Year Results on February 11, 2010
PRNewswire (Tue, Jan 26)
• 2 Stocks Hitting Low Notes
at Motley Fool (Mon, Jan 25)
• AMAG Pharma Guides on Feraheme
Zacks.com (Mon, Jan 11)
• China Biotech Week in Review: New Investments for a New Year
at Seeking Alpha (Sun, Jan 10)
• 3SBio Inc. Applies for SFDA Registrational Trial for Feraheme(TM)
PRNewswire (Fri, Jan 8)
• Prospecting for Stocks: QLT
at Motley Fool (Wed, Dec 16)
• The Wrong Way to Invest in China
at Motley Fool (Thu, Dec 10)
• Build Your Fortune With These Winners
at Motley Fool (Thu, Dec 3)
• Biotech Bargains for Your Portfolio
at Motley Fool (Fri, Nov 27)
• 3SBIO INC Earnings Call scheduled for 8:00 am ET today
CCBN (Fri, Nov 13)
• 3SBio Inc. Announces Unaudited Third Quarter 2009 Results
PRNewswire (Thu, Nov 12)
More Headlines for SSRX...
ANALYST
EPS Est (next year) (Dec-09) : 0.56
EPS Est (in 2 years) (Dec-10) : 0.65
Avg Rec (current)*: 1.5
PEG Ratio: 1.14
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
3SBio Inc., a biotechnology company, focuses on the research, development, manufacture, and marketing of biopharmaceutical products primarily in the People’s Republic of China.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices